In a recent study posted to bioRxiv* preprint server, researchers assessed the neutralization efficacy of a self-amplifying ribonucleic acid (saRNA) vaccine targeting severe acute respiratory syndrome ...
In their Perspective article (Sept. 9 issue), 1 Rapeport et al. describe their historic SARS-CoV-2 human challenge studies. Challenge models can generate crucial knowledge in this pandemic and in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results